🔎 Trials Near Me

Beranda › Dermatomiositis › Maryland

Uji klinis Dermatomiositis di Maryland

9 studi untuk Dermatomiositis mencari peserta di lokasi di Maryland.

Kota di Maryland

Teks studi resmi (Bahasa Inggris)

FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07111065

Environmental Risk Factors for the Anti-synthetase Syndrome

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT01276470

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

  • Research Site, Baltimore
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06455449

Natural History of Inflammatory Muscle Diseases

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05738824

Adult and Juvenile Myositis

  • National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT00017914

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • National Institutes of Health - Accepting Adult and Juvenile Patients, Bethesda
Menerima pesertaFase 2/3
Usia 6 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Johns Hopkins Hospital, Baltimore
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • Johns Hopkins University, Baltimore
Menerima pesertaFase 1
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT06371417

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.